A green HPLC method for determination of mirtazapine in pharmaceutical products: Development, validation, and greenness Assessment

• Autorzy: Demir Ibrahim , Bulduk Ibrahim , Enginar Hüseyin , Çifci Cemal

Identyfikatory

DOI

10.1556/1326.2023.01155

• Języki publikacji: EN

Abstrakty

EN

Mirtazapine is an antidepressant medication used to treat the major depressive disorder in adults. In this study, two different chromatographic methods were developed for the determination of mirtazapine in pharmaceutical products. In the first method, An Extend C18 column (250 3 4.6 mm, 5 μm) was used and the temperature was kept constant at 25 8C. The mobile phase was determined as 0.1% formic acid solution and acetonitrile (80/20, v/v), and isocratic elution was applied. The flow rate of the mobile phase was determined as 1.0 mL min1 and the injection volume was 20 μL. Detection was performed at 291 nm. using a UV detector. In the second method, ethanol was used as the organic modifier. The only difference between these methods was the organic modifier. All other conditions of the methods were the same. Both chromatographic methods were validated by ICH guidelines for various parameters such as selectivity, linearity, accuracy, precision, detection and quantification limit, and robustness. The determination coefficients of chromatographic methods were greater than 0.999 in the concentration range of 5–30 μgmL1. of mirtazapine. Later, these chromatographic methods were applied to pharmaceutical formulations. Comparison of the obtained results in terms of means was made using Student’s (t) test, and comparisons in terms of standard deviations were made using the Fischer (F) test. It was observed that there was no significant difference between these methods. These two methods were then evaluated using the AGREE-Analytical GREEnness metric software. The chromatographic method using ethanol as an organic modifier has been proposed as an excellent eco-friendly and analyst-friendly alternative for the determination of mirtazapine in pharmaceutical formulations.

Słowa kluczowe

EN

mirtazapine; pharmaceutical forms; HPLC; green analytical chemistry; method validation

• Wydawca: University of Silesia in Katowice ; Akademiai Kiado
• Czasopismo: Acta Chromatographica
• Rocznik: 2024
• Tom: Vol. 36, no. 3
• Strony: 237--246
• Opis fizyczny: Bibliogr. 31 poz. rys., wykr.

Twórcy

autor

Demir Ibrahim

• Department of Chemistry, Faculty of Arts and Science, Afyon Kocatepe University, Afyonkarahisar, Turkey

autor

Bulduk Ibrahim

• Department of Chemical Engineering, Faculty of Engineering, Afyon Kocatepe University, Afyonkarahisar, Turkey

autor

Enginar Hüseyin

• Department of Chemistry, Faculty of Arts and Science, Afyon Kocatepe University, Afyonkarahisar, Turkey

autor

Çifci Cemal

• Department of Chemical Engineering, Faculty of Engineering, Afyon Kocatepe University, Afyonkarahisar, Turkey

Bibliografia

• 1. Kokilambigai, K. S.; Lakshmi, K. S. Analytical quality by design assisted RP-HPLC method for quantifying atorvastatin with a Green analytical chemistry perspective. J. Chromatogr. Open 2022, 2, 100052. https://doi.org/10.1016/j.jcoa.2022.100052.
• 2. Yabré, M.; Ferey, L.; Somé, I. T.; Gaudin, K. Greening reversedphase liquid chromatography methods using alternative solvents for pharmaceutical analysis. Molecules 2018, 23(5), 1065. https://doi.org/10.3390/molecules23051065.
• 3. Snyder, L. R.; Kirkland, J. J.; Dolan, J. W. Introduction to Modern Liquid Chromatography; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2009.
• 4. Welch, C. J.; Wu, N.; Biba, M.; Hartman, R.; Brkovic, T.; Gong, X.; Helmy, R.; Schafer, W.; Cuff, J.; Pirzada, Z. Greening analytical chromatography. TrAC Trends Anal. Chem. 2010, 29, 667–80. https://doi.org/10.1016/j.trac.2010.03.008.
• 5. ICH harmonised tripartite guideline impurities: guideline for residua solvents Q3C (R5). Curr. Step. 2005, 4, 509.
• 6. Sheldon, R. A. Fundamentals of green chemistry: efficiency in re action design. Chem. Soc. Rev. 2012, 41, 1437–51. https://doi.org/10.1039/C1CS15219J.
• 7.Welch, C. J.; Wu, N.; Biba, M.; Hartman, R.; Brkovic, T.; Gong, X.; Helmy, R.; Schafer, W.; Cuff, J.; Pirzada, Z. Greening analytical chromatography. TrAC Trends Anal. Chem. 2010, 29, 667–80.
• 8. Płotka, J.; Tobiszewski, M.; Sulej, A. M.; Kupska, M.; Górecki, T.; Namiesnik, J. Green chromatography. J. Chromatogr. A. 2013, 1307, 1–20.
• 9. Saini, B.; Kaushal, M.; Bansal, G. A validated direct spectrofluorimetric method for quantification of mirtazapine in human whole blood. Spectroscopy 2010, 24, 641–9.
• 10. Shen, Y.; Chen, B.; van Beek, T. A. Alternative solvents can make preparative liquid chromatography greener. Green. Chem. 2015, 17, 4073–81.
• 11. Gillman, P. K. A systematic review of the serotonergic effects of mirtazapine: implications for its dual action status. Hum. Psychopharmacol. Clin. Exp. 2006, 21(2), 117–25.
• 12. https://pubchem.ncbi.nlm.nih.gov/compound/Mirtazapine.
• 13. Karas¸en, N.; Altinöz, S. Determination of mirtazapine in tablets by UV spectrophotometric and derivative spectrophotometric methods. J. Pharm. Biomed. Anal. 2000, 24, 11–7.
• 14. Labat, L.; Dallet, P.; Kumer, E.; Dubost, J. P. Spectrophotometric, spectrofluorimetric, HPLC and CZE determination of mirtazapine in pharmaceutical tablets. J. Pharm. Biomed. Anal. 2002, 28, 365–71.
• 15. Saini, B.; Kaushal, M.; Bansal, G. A validated direct spectrofluorimetric method for quantification of mirtazapine in human whole blood. Spectroscopy 2010, 24, 641–9.
• 16. Youssef, R. M. Determination of mirtazapine in spiked human plasma and tablets by first derivative spectrofluorimetric method, Saudi. Pharm. J. 2010, 18, 45–9.
• 17. Kumar, D. R.; Lakshmi, V. N.; Vardhan, S. V. M.; Rambabu, C. Determination of mirtazapine in tablet dosage forms by visible spectrophotometry. Biosci. Biotech. Res. Asia. 2008, 5, 863–6.
• 18. Ptacek, P.; Klıma, J.; Mace, J. Determination of mirtazapine In human plasma by liquid chromatography. J. Chromatogr. 2003, 794, 323–8.
• 19. Romiguieres, T.; Pehourcq, F.; Matoga, M.; Begaud, B.; Jarry, C. Determination of mirtazapine and its dimethyl metabolite In plasma by high-performance liquid chromatography with ultrafiolet detection. Application to the management of acute intoxication. J. Chromatog. B Anal. Technol. Biomed. Life Sci. 2002, 775, 163–8.
• 20. Lavasani, H.; Giorgi, M.; Sheikholeslami, B.; Hedayati, M.; Rouini, M. R. A rapid and sensitive HPLC-fluorescence method for determination of mirtazapine and its two major metabolites in human plasma. Heal. Serv. Iran. J. Pharm. Res. 2014, 13, 853–62.
• 21. Mandrioli, R.; Pucci, V.; Sabbioni, C.; Bartoletti, C.; Fanali, S.; Raggi, M. A. Enantioselective determination of the novel antidepressant mirtazapine and its active demethylated metabolite In human plasma using capillary electrophoresis. J. Chromatogr. A. 2004, 1051, 253–60.
• 22. de Santana, F. J.; Lanchote, V. L.; Bonato, P. S. Capillary electrophoretic chiral determination of mirtazapine and its main metabolites in human urine after enzymatic hydrolysis. Electrophoresis 2008, 29, 3924–32.
• 23. Hong, X.; Yao, Y.; Hong, S.; Lei, C. LC/MS/MS analysis of mirtazapine in plasma and determination of pharmacokinetic data for rats. Chromatographia, 68, 6.
• 24. Wang, X. Q.; Pan, X. J.; Lin, G. Y.; Xiang, Z.; Wang, X. B.; Wu, J. Z.; Lin, D. Simultaneous determination of clozapine, olanzapine and mirtazapine in human plasma by LC-MS/MS. Fa Yi Xue Za Zhi 2009, 25, 123–6.
• 25. Kuchekar, S. R.; Kundlik, M. L.; Zaware, B. H. Rapid quantification of mirtazapine and desmethyl mirtazapine in human plasma by LC-ESI-MS/MS: application to a bioequivalence study. J. Saudi Chem. Soc. 2011, 15, 9.
• 26. Wille, S. M.; Maudens, K. E.; Van Peteghem, C. H.; Lambert, W. E. Development of a solid phase extraction for 13 ‘new’ generation antidepressants and their active metabolites for gas chromatographic–mass spectrometric analysis. J. Chromatogr. A. 2005, 1098, 19–29.
• 27. Wille, S. M.; Van Hee, P.; Neels, H. M.; Van Peteghem, C. H.; Lambert, W. E. Comparison of electron and chemical ionization modes by validation of a quantitative gas chromatographic–mass spectrometric assay of new generation antidepressants and their active metabolites in plasma, J. Chromatogr. A. 2007, 1176, 236–45.
• 28. Validation of analytical procedures: text and methodology Q2(R1)- ICH harmonized tripartite guideline. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2005.
• 29. AOAC International Appendix F: guidelines for standard methods performance requirements. AOAC Official Method Anal. AOAC Int. 2016, 1–18.
• 30. Płotka-Wasylka, J. A. New tool for the evaluation of the analytical procedure: green analytical procedure index. Talanta 2018, 181, 204–9.
• 31. Pena-Pereira, F.; Wojnowski, W.; Tobiszewski, M. AGREE—analytical GREEnness metric approach and software. Anal. Chem. 2020, 92, 10076–82.